APA (7th ed.) Citation

Krawczyk, A., Strzałka-Mrozik, B., Juszczyk, K., Kimsa-Dudek, M., Wcisło-Dziadecka, D., & Gola, J. (2023). The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis. Current pharmaceutical biotechnology, 24(2), 330. https://doi.org/10.2174/1389201023666220628111644

Chicago Style (17th ed.) Citation

Krawczyk, Agata, Barbara Strzałka-Mrozik, Karol Juszczyk, Magdalena Kimsa-Dudek, Dominika Wcisło-Dziadecka, and Joanna Gola. "The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis." Current Pharmaceutical Biotechnology 24, no. 2 (2023): 330. https://doi.org/10.2174/1389201023666220628111644.

MLA (9th ed.) Citation

Krawczyk, Agata, et al. "The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis." Current Pharmaceutical Biotechnology, vol. 24, no. 2, 2023, p. 330, https://doi.org/10.2174/1389201023666220628111644.